Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 8Phase 1/2 4Phase 3 1Phase 2/3 1

Status

Completed 7Terminated 4Active not recruiting 4Withdrawn 2Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Other solid neoplasm 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Ovarian Neoplasms 1Advanced Solid Tumor, Adult 1

Interventions

pembrolizumab 75Carboplatin 61Cyclophosphamide 58Nivolumab 50Paclitaxel 47Gemcitabine 44Cisplatin 43Dexamethasone 41Radiotherapy 35Rituximab 32Capecitabine 31Docetaxel 29Bevacizumab 29fludarabine 27atezolizumab 26Cytarabine 26avelumab 24Trastuzumab 23Oxaliplatin 23Lenalidomide 23Cetuximab 23venetoclax 22Fluorouracil 22Azacitidine 22Temozolomide 21Ipilimumab 21130-nm albumin-bound paclitaxel 21fludarabine phosphate 20Filgrastim 20Bortezomib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × niraparib × Clear all
NCT04972110 2025-10-30

ATTACC

Repare Therapeutics

Phase 1/2 Terminated
156 enrolled 19 charts
Other solid neoplasm

Advanced Solid Tumor, Adult

NCT04926324 2025-06-29

A Safety Study Adding Niraparib and Dostarlimab to Radiation Therapy for Rectal Cancers

University of Iowa

Phase 1/2 Terminated
3 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04826198 2024-12-05

REVOCAN

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1/2 Terminated
13 enrolled
Gynecologic

Ovarian Neoplasms

NCT03644342 2024-09-03

NIVIX

Baylor College of Medicine

Phase 1/2 Terminated
4 enrolled 8 charts
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡